Atlantic International (ATLN) Stock Price, News & Analysis

Company Overview

Atlantic International Corp. engages in the design, development, and manufacture of genetic analysis technologies. Its services include RNA sequencing and DNA sequencing. The company was founded by William C. St. Laurent and Daniel R. Jones in 2013 and is headquartered in Billercia, MA.

Key Stats

• Today's Range: $1.68 to $2.35
• 50-Day Range: $1.78 to $4.53
• 52-Week Range: $1.68 to $7.97
• Volume: 845,588 shs
• Average Volume: 22,167 shs
• Market Capitalization: $109.74 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ATLN Stock Analysis - Frequently Asked Questions

How have ATLN shares performed this year?

Atlantic International's stock was trading at $6.55 at the beginning of the year. Since then, ATLN shares have decreased by 72.8% and is now trading at $1.78.
View the best growth stocks for 2025 here.

How were Atlantic International's earnings last quarter?

Atlantic International Corp. (NASDAQ:ATLN) released its quarterly earnings results on Friday, March, 28th. The company reported ($1.64) EPS for the quarter. Atlantic International had a negative trailing twelve-month return on equity of 3,234.95% and a negative net margin of 31.78%.

How do I buy shares of Atlantic International?

Shares of ATLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 3/28/2025
• Today: 6/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: BUSINESS SVCS
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:ATLN
• Previous Symbol: NASDAQ:ATLN
• CIK: 1605888
• Web: www.atlantic-international.com
• Phone: 201-899-4470
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($3.96)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$135.48 million
• Net Margins: -31.78%
• Pretax Margin: -30.28%
• Return on Equity: -3,234.95%
• Return on Assets: -85.31%

Debt

• Debt-to-Equity Ratio: 2.26
• Current Ratio: 0.62
• Quick Ratio: 0.62

Sales & Book Value

• Annual Sales: $442.61 million
• Price / Sales: 0.25
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.24) per share
• Price / Book: -7.42

Miscellaneous

• Outstanding Shares: 61,650,000
• Free Float: 53,266,000
• Market Cap: $109.74 million
• Optionable: N/A
• Beta: 1.17